Immune checkpoint inhibitors combined with chemotherapy vs chemotherapy alone in advanced or metastatic triple-negative breast cancer: a systematic review and random-effects meta-analysis of randomized controlled trials
Randomized controlled trials (RCTs) evaluating immune checkpoint inhibitors (ICIs) in combination with chemotherapy for treating metastatic and locally advancedtriple-negative breast cancer (TNBC) have reported heterogeneous results, particularly for overall survival (OS). We conducted a systematic review and meta-...